Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
CA 2373375 C · Owner: Vsl Pharmaceuticals, Inc. · Inventors: De Simone, Claudio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The disclosure is of a combination of lactic acid bacteria comprising: (a) a first component consisting of at least one strain of H2O2-producing lactic acid bacteria; and (b) a second component consisting of at least one strain of arginine-utilizing lactic acid bacteria. The disclosure is also of the use of this combination for making a food supplement a hygiene product or a , pharmaceutical preparation for the prevention and/or treatment of infections and inflammatory conditions caused by bacteria viruses or fungi, especially , in the mouth vagina, urethra, nose, eyes and ears.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 16, 2000 and granted January 14, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 16, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 16, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.